Pharma & Healthcare
Global Age Related Macular Degeneration Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- May 05, 25
- ID: 223265
- Pages: 65
- Figures: 71
- Views: 46
The global Age Related Macular Degeneration Drug market size was US$ 8657 million in 2024 and is forecast to a readjusted size of US$ 12860 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.
The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.
The global Age Related Macular Degeneration Drug market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
By Type: (Dominant Segment vs High-Margin Innovation)
Lucentis
Eylea
Avastin
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals
Clinics
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Regeneron Pharmaceuticals in Europe)
- Emerging Product Trends: Lucentis adoption vs. Eylea premiumization
- Demand-Side Dynamics: Hospitals growth in China vs. Clinics potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Age Related Macular Degeneration Drug market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Eylea in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Lucentis dominance in Europe vs. Eylea demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.
The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.
The global Age Related Macular Degeneration Drug market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
By Type: (Dominant Segment vs High-Margin Innovation)
Lucentis
Eylea
Avastin
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals
Clinics
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Regeneron Pharmaceuticals in Europe)
- Emerging Product Trends: Lucentis adoption vs. Eylea premiumization
- Demand-Side Dynamics: Hospitals growth in China vs. Clinics potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Age Related Macular Degeneration Drug market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Eylea in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Lucentis dominance in Europe vs. Eylea demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Age Related Macular Degeneration Drug Product Scope
1.2 Age Related Macular Degeneration Drug by Type
1.2.1 Global Age Related Macular Degeneration Drug Sales by Type (2020 & 2024 & 2031)
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Others
1.3 Age Related Macular Degeneration Drug by Application
1.3.1 Global Age Related Macular Degeneration Drug Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts (2020-2031)
1.4.1 Global Age Related Macular Degeneration Drug Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Age Related Macular Degeneration Drug Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Age Related Macular Degeneration Drug Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Age Related Macular Degeneration Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Age Related Macular Degeneration Drug Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Age Related Macular Degeneration Drug Sales Market Share by Region (2020-2025)
2.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2020-2025)
2.3 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Age Related Macular Degeneration Drug Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Age Related Macular Degeneration Drug Market Size and Prospective (2020-2031)
2.4.2 Europe Age Related Macular Degeneration Drug Market Size and Prospective (2020-2031)
2.4.3 China Age Related Macular Degeneration Drug Market Size and Prospective (2020-2031)
2.4.4 Japan Age Related Macular Degeneration Drug Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Age Related Macular Degeneration Drug Historic Market Review by Type (2020-2025)
3.1.1 Global Age Related Macular Degeneration Drug Sales by Type (2020-2025)
3.1.2 Global Age Related Macular Degeneration Drug Revenue by Type (2020-2025)
3.1.3 Global Age Related Macular Degeneration Drug Price by Type (2020-2025)
3.2 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2026-2031)
3.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2026-2031)
3.2.3 Global Age Related Macular Degeneration Drug Price Forecast by Type (2026-2031)
3.3 Different Types Age Related Macular Degeneration Drug Representative Players
4 Global Market Size by Application
4.1 Global Age Related Macular Degeneration Drug Historic Market Review by Application (2020-2025)
4.1.1 Global Age Related Macular Degeneration Drug Sales by Application (2020-2025)
4.1.2 Global Age Related Macular Degeneration Drug Revenue by Application (2020-2025)
4.1.3 Global Age Related Macular Degeneration Drug Price by Application (2020-2025)
4.2 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Application (2026-2031)
4.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2026-2031)
4.2.3 Global Age Related Macular Degeneration Drug Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Age Related Macular Degeneration Drug Application
5 Competition Landscape by Players
5.1 Global Age Related Macular Degeneration Drug Sales by Players (2020-2025)
5.2 Global Top Age Related Macular Degeneration Drug Players by Revenue (2020-2025)
5.3 Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2024)
5.4 Global Age Related Macular Degeneration Drug Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Age Related Macular Degeneration Drug, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Age Related Macular Degeneration Drug, Product Type & Application
5.7 Global Key Manufacturers of Age Related Macular Degeneration Drug, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Age Related Macular Degeneration Drug Sales by Company
6.1.1.1 North America Age Related Macular Degeneration Drug Sales by Company (2020-2025)
6.1.1.2 North America Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
6.1.2 North America Age Related Macular Degeneration Drug Sales Breakdown by Type (2020-2025)
6.1.3 North America Age Related Macular Degeneration Drug Sales Breakdown by Application (2020-2025)
6.1.4 North America Age Related Macular Degeneration Drug Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Age Related Macular Degeneration Drug Sales by Company
6.2.1.1 Europe Age Related Macular Degeneration Drug Sales by Company (2020-2025)
6.2.1.2 Europe Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
6.2.2 Europe Age Related Macular Degeneration Drug Sales Breakdown by Type (2020-2025)
6.2.3 Europe Age Related Macular Degeneration Drug Sales Breakdown by Application (2020-2025)
6.2.4 Europe Age Related Macular Degeneration Drug Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Age Related Macular Degeneration Drug Sales by Company
6.3.1.1 China Age Related Macular Degeneration Drug Sales by Company (2020-2025)
6.3.1.2 China Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
6.3.2 China Age Related Macular Degeneration Drug Sales Breakdown by Type (2020-2025)
6.3.3 China Age Related Macular Degeneration Drug Sales Breakdown by Application (2020-2025)
6.3.4 China Age Related Macular Degeneration Drug Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Age Related Macular Degeneration Drug Sales by Company
6.4.1.1 Japan Age Related Macular Degeneration Drug Sales by Company (2020-2025)
6.4.1.2 Japan Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
6.4.2 Japan Age Related Macular Degeneration Drug Sales Breakdown by Type (2020-2025)
6.4.3 Japan Age Related Macular Degeneration Drug Sales Breakdown by Application (2020-2025)
6.4.4 Japan Age Related Macular Degeneration Drug Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Regeneron Pharmaceuticals
7.1.1 Regeneron Pharmaceuticals Company Information
7.1.2 Regeneron Pharmaceuticals Business Overview
7.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Products Offered
7.1.5 Regeneron Pharmaceuticals Recent Development
7.2 Bayer HealthCare
7.2.1 Bayer HealthCare Company Information
7.2.2 Bayer HealthCare Business Overview
7.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Products Offered
7.2.5 Bayer HealthCare Recent Development
7.3 Novartis
7.3.1 Novartis Company Information
7.3.2 Novartis Business Overview
7.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Novartis Age Related Macular Degeneration Drug Products Offered
7.3.5 Novartis Recent Development
7.4 Roche
7.4.1 Roche Company Information
7.4.2 Roche Business Overview
7.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Roche Age Related Macular Degeneration Drug Products Offered
7.4.5 Roche Recent Development
7.5 Kanghong Pharma
7.5.1 Kanghong Pharma Company Information
7.5.2 Kanghong Pharma Business Overview
7.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Products Offered
7.5.5 Kanghong Pharma Recent Development
8 Age Related Macular Degeneration Drug Manufacturing Cost Analysis
8.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
8.4 Age Related Macular Degeneration Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Age Related Macular Degeneration Drug Distributors List
9.3 Age Related Macular Degeneration Drug Customers
10 Age Related Macular Degeneration Drug Market Dynamics
10.1 Age Related Macular Degeneration Drug Industry Trends
10.2 Age Related Macular Degeneration Drug Market Drivers
10.3 Age Related Macular Degeneration Drug Market Challenges
10.4 Age Related Macular Degeneration Drug Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Age Related Macular Degeneration Drug Product Scope
1.2 Age Related Macular Degeneration Drug by Type
1.2.1 Global Age Related Macular Degeneration Drug Sales by Type (2020 & 2024 & 2031)
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Others
1.3 Age Related Macular Degeneration Drug by Application
1.3.1 Global Age Related Macular Degeneration Drug Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts (2020-2031)
1.4.1 Global Age Related Macular Degeneration Drug Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Age Related Macular Degeneration Drug Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Age Related Macular Degeneration Drug Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Age Related Macular Degeneration Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Age Related Macular Degeneration Drug Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Age Related Macular Degeneration Drug Sales Market Share by Region (2020-2025)
2.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2020-2025)
2.3 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Age Related Macular Degeneration Drug Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Age Related Macular Degeneration Drug Market Size and Prospective (2020-2031)
2.4.2 Europe Age Related Macular Degeneration Drug Market Size and Prospective (2020-2031)
2.4.3 China Age Related Macular Degeneration Drug Market Size and Prospective (2020-2031)
2.4.4 Japan Age Related Macular Degeneration Drug Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Age Related Macular Degeneration Drug Historic Market Review by Type (2020-2025)
3.1.1 Global Age Related Macular Degeneration Drug Sales by Type (2020-2025)
3.1.2 Global Age Related Macular Degeneration Drug Revenue by Type (2020-2025)
3.1.3 Global Age Related Macular Degeneration Drug Price by Type (2020-2025)
3.2 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2026-2031)
3.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2026-2031)
3.2.3 Global Age Related Macular Degeneration Drug Price Forecast by Type (2026-2031)
3.3 Different Types Age Related Macular Degeneration Drug Representative Players
4 Global Market Size by Application
4.1 Global Age Related Macular Degeneration Drug Historic Market Review by Application (2020-2025)
4.1.1 Global Age Related Macular Degeneration Drug Sales by Application (2020-2025)
4.1.2 Global Age Related Macular Degeneration Drug Revenue by Application (2020-2025)
4.1.3 Global Age Related Macular Degeneration Drug Price by Application (2020-2025)
4.2 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Application (2026-2031)
4.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2026-2031)
4.2.3 Global Age Related Macular Degeneration Drug Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Age Related Macular Degeneration Drug Application
5 Competition Landscape by Players
5.1 Global Age Related Macular Degeneration Drug Sales by Players (2020-2025)
5.2 Global Top Age Related Macular Degeneration Drug Players by Revenue (2020-2025)
5.3 Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2024)
5.4 Global Age Related Macular Degeneration Drug Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Age Related Macular Degeneration Drug, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Age Related Macular Degeneration Drug, Product Type & Application
5.7 Global Key Manufacturers of Age Related Macular Degeneration Drug, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Age Related Macular Degeneration Drug Sales by Company
6.1.1.1 North America Age Related Macular Degeneration Drug Sales by Company (2020-2025)
6.1.1.2 North America Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
6.1.2 North America Age Related Macular Degeneration Drug Sales Breakdown by Type (2020-2025)
6.1.3 North America Age Related Macular Degeneration Drug Sales Breakdown by Application (2020-2025)
6.1.4 North America Age Related Macular Degeneration Drug Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Age Related Macular Degeneration Drug Sales by Company
6.2.1.1 Europe Age Related Macular Degeneration Drug Sales by Company (2020-2025)
6.2.1.2 Europe Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
6.2.2 Europe Age Related Macular Degeneration Drug Sales Breakdown by Type (2020-2025)
6.2.3 Europe Age Related Macular Degeneration Drug Sales Breakdown by Application (2020-2025)
6.2.4 Europe Age Related Macular Degeneration Drug Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Age Related Macular Degeneration Drug Sales by Company
6.3.1.1 China Age Related Macular Degeneration Drug Sales by Company (2020-2025)
6.3.1.2 China Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
6.3.2 China Age Related Macular Degeneration Drug Sales Breakdown by Type (2020-2025)
6.3.3 China Age Related Macular Degeneration Drug Sales Breakdown by Application (2020-2025)
6.3.4 China Age Related Macular Degeneration Drug Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Age Related Macular Degeneration Drug Sales by Company
6.4.1.1 Japan Age Related Macular Degeneration Drug Sales by Company (2020-2025)
6.4.1.2 Japan Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
6.4.2 Japan Age Related Macular Degeneration Drug Sales Breakdown by Type (2020-2025)
6.4.3 Japan Age Related Macular Degeneration Drug Sales Breakdown by Application (2020-2025)
6.4.4 Japan Age Related Macular Degeneration Drug Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Regeneron Pharmaceuticals
7.1.1 Regeneron Pharmaceuticals Company Information
7.1.2 Regeneron Pharmaceuticals Business Overview
7.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Products Offered
7.1.5 Regeneron Pharmaceuticals Recent Development
7.2 Bayer HealthCare
7.2.1 Bayer HealthCare Company Information
7.2.2 Bayer HealthCare Business Overview
7.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Products Offered
7.2.5 Bayer HealthCare Recent Development
7.3 Novartis
7.3.1 Novartis Company Information
7.3.2 Novartis Business Overview
7.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Novartis Age Related Macular Degeneration Drug Products Offered
7.3.5 Novartis Recent Development
7.4 Roche
7.4.1 Roche Company Information
7.4.2 Roche Business Overview
7.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Roche Age Related Macular Degeneration Drug Products Offered
7.4.5 Roche Recent Development
7.5 Kanghong Pharma
7.5.1 Kanghong Pharma Company Information
7.5.2 Kanghong Pharma Business Overview
7.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Products Offered
7.5.5 Kanghong Pharma Recent Development
8 Age Related Macular Degeneration Drug Manufacturing Cost Analysis
8.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
8.4 Age Related Macular Degeneration Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Age Related Macular Degeneration Drug Distributors List
9.3 Age Related Macular Degeneration Drug Customers
10 Age Related Macular Degeneration Drug Market Dynamics
10.1 Age Related Macular Degeneration Drug Industry Trends
10.2 Age Related Macular Degeneration Drug Market Drivers
10.3 Age Related Macular Degeneration Drug Market Challenges
10.4 Age Related Macular Degeneration Drug Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Age Related Macular Degeneration Drug Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Age Related Macular Degeneration Drug Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Age Related Macular Degeneration Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Age Related Macular Degeneration Drug Sales (K Units) by Region (2020-2025)
Table 5. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2020-2025)
Table 6. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Age Related Macular Degeneration Drug Revenue Share by Region (2020-2025)
Table 8. Global Age Related Macular Degeneration Drug Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Age Related Macular Degeneration Drug Revenue Share Forecast by Region (2026-2031)
Table 12. Global Age Related Macular Degeneration Drug Sales by Type (K Units) & (2020-2025)
Table 13. Global Age Related Macular Degeneration Drug Sales Share by Type (2020-2025)
Table 14. Global Age Related Macular Degeneration Drug Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Age Related Macular Degeneration Drug Price by Type (USD/Unit) & (2020-2025)
Table 16. Global Age Related Macular Degeneration Drug Sales by Type (K Units) & (2026-2031)
Table 17. Global Age Related Macular Degeneration Drug Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Age Related Macular Degeneration Drug Price by Type (USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Age Related Macular Degeneration Drug Sales by Application (K Units) & (2020-2025)
Table 21. Global Age Related Macular Degeneration Drug Sales Share by Application (2020-2025)
Table 22. Global Age Related Macular Degeneration Drug Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Age Related Macular Degeneration Drug Price by Application (USD/Unit) & (2020-2025)
Table 24. Global Age Related Macular Degeneration Drug Sales by Application (K Units) & (2026-2031)
Table 25. Global Age Related Macular Degeneration Drug Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Age Related Macular Degeneration Drug Price by Application (USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in Age Related Macular Degeneration Drug Application
Table 28. Global Age Related Macular Degeneration Drug Sales by Company (K Units) & (2020-2025)
Table 29. Global Age Related Macular Degeneration Drug Sales Share by Company (2020-2025)
Table 30. Global Age Related Macular Degeneration Drug Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Age Related Macular Degeneration Drug Revenue Share by Company (2020-2025)
Table 32. Global Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2024)
Table 33. Global Market Age Related Macular Degeneration Drug Average Price by Company (USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Age Related Macular Degeneration Drug, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Age Related Macular Degeneration Drug, Product Type & Application
Table 36. Global Key Manufacturers of Age Related Macular Degeneration Drug, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 39. North America Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 40. North America Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 42. North America Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 43. North America Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 44. North America Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 45. North America Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Table 46. Europe Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 47. Europe Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 48. Europe Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 50. Europe Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 51. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 52. Europe Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 53. Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Table 54. China Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 55. China Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 56. China Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 58. China Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 59. China Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 60. China Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 61. China Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Table 62. Japan Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 63. Japan Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 64. Japan Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 66. Japan Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 67. Japan Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 68. Japan Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 69. Japan Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Table 70. Regeneron Pharmaceuticals Company Information
Table 71. Regeneron Pharmaceuticals Description and Business Overview
Table 72. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product
Table 74. Regeneron Pharmaceuticals Recent Development
Table 75. Bayer HealthCare Company Information
Table 76. Bayer HealthCare Description and Business Overview
Table 77. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Bayer HealthCare Age Related Macular Degeneration Drug Product
Table 79. Bayer HealthCare Recent Development
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Age Related Macular Degeneration Drug Product
Table 84. Novartis Recent Development
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Roche Age Related Macular Degeneration Drug Product
Table 89. Roche Recent Development
Table 90. Kanghong Pharma Company Information
Table 91. Kanghong Pharma Description and Business Overview
Table 92. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Kanghong Pharma Age Related Macular Degeneration Drug Product
Table 94. Kanghong Pharma Recent Development
Table 95. Production Base and Market Concentration Rate of Raw Material
Table 96. Key Suppliers of Raw Materials
Table 97. Age Related Macular Degeneration Drug Distributors List
Table 98. Age Related Macular Degeneration Drug Customers List
Table 99. Age Related Macular Degeneration Drug Market Trends
Table 100. Age Related Macular Degeneration Drug Market Drivers
Table 101. Age Related Macular Degeneration Drug Market Challenges
Table 102. Age Related Macular Degeneration Drug Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration Drug Product Picture
Figure 2. Global Age Related Macular Degeneration Drug Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Age Related Macular Degeneration Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Lucentis Product Picture
Figure 5. Eylea Product Picture
Figure 6. Avastin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Age Related Macular Degeneration Drug Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Age Related Macular Degeneration Drug Sales Market Share by Application in 2024 & 2031
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Others Examples
Figure 13. Global Age Related Macular Degeneration Drug Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Age Related Macular Degeneration Drug Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 16. Global Age Related Macular Degeneration Drug Price Trends Growth Rate (2020-2031) & (USD/Unit)
Figure 17. Age Related Macular Degeneration Drug Report Years Considered
Figure 18. Global Market Age Related Macular Degeneration Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Age Related Macular Degeneration Drug Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Age Related Macular Degeneration Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 22. Europe Age Related Macular Degeneration Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 24. China Age Related Macular Degeneration Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. China Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 26. Japan Age Related Macular Degeneration Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 28. Global Age Related Macular Degeneration Drug Revenue Share by Type (2020-2025)
Figure 29. Global Age Related Macular Degeneration Drug Sales Share by Type (2026-2031)
Figure 30. Global Age Related Macular Degeneration Drug Revenue Share by Type (2026-2031)
Figure 31. Global Age Related Macular Degeneration Drug Revenue Share by Application (2020-2025)
Figure 32. Global Age Related Macular Degeneration Drug Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Age Related Macular Degeneration Drug Sales Share by Application (2026-2031)
Figure 34. Global Age Related Macular Degeneration Drug Revenue Share by Application (2026-2031)
Figure 35. Global Age Related Macular Degeneration Drug Sales Share by Company (2024)
Figure 36. Global Age Related Macular Degeneration Drug Revenue Share by Company (2024)
Figure 37. Global 5 Largest Age Related Macular Degeneration Drug Players Market Share by Revenue in Age Related Macular Degeneration Drug: 2020 & 2024
Figure 38. Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure 40. Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure 41. Age Related Macular Degeneration Drug Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Table 1. Global Age Related Macular Degeneration Drug Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Age Related Macular Degeneration Drug Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Age Related Macular Degeneration Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Age Related Macular Degeneration Drug Sales (K Units) by Region (2020-2025)
Table 5. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2020-2025)
Table 6. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Age Related Macular Degeneration Drug Revenue Share by Region (2020-2025)
Table 8. Global Age Related Macular Degeneration Drug Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Age Related Macular Degeneration Drug Revenue Share Forecast by Region (2026-2031)
Table 12. Global Age Related Macular Degeneration Drug Sales by Type (K Units) & (2020-2025)
Table 13. Global Age Related Macular Degeneration Drug Sales Share by Type (2020-2025)
Table 14. Global Age Related Macular Degeneration Drug Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Age Related Macular Degeneration Drug Price by Type (USD/Unit) & (2020-2025)
Table 16. Global Age Related Macular Degeneration Drug Sales by Type (K Units) & (2026-2031)
Table 17. Global Age Related Macular Degeneration Drug Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Age Related Macular Degeneration Drug Price by Type (USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Age Related Macular Degeneration Drug Sales by Application (K Units) & (2020-2025)
Table 21. Global Age Related Macular Degeneration Drug Sales Share by Application (2020-2025)
Table 22. Global Age Related Macular Degeneration Drug Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Age Related Macular Degeneration Drug Price by Application (USD/Unit) & (2020-2025)
Table 24. Global Age Related Macular Degeneration Drug Sales by Application (K Units) & (2026-2031)
Table 25. Global Age Related Macular Degeneration Drug Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Age Related Macular Degeneration Drug Price by Application (USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in Age Related Macular Degeneration Drug Application
Table 28. Global Age Related Macular Degeneration Drug Sales by Company (K Units) & (2020-2025)
Table 29. Global Age Related Macular Degeneration Drug Sales Share by Company (2020-2025)
Table 30. Global Age Related Macular Degeneration Drug Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Age Related Macular Degeneration Drug Revenue Share by Company (2020-2025)
Table 32. Global Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2024)
Table 33. Global Market Age Related Macular Degeneration Drug Average Price by Company (USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Age Related Macular Degeneration Drug, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Age Related Macular Degeneration Drug, Product Type & Application
Table 36. Global Key Manufacturers of Age Related Macular Degeneration Drug, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 39. North America Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 40. North America Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 42. North America Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 43. North America Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 44. North America Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 45. North America Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Table 46. Europe Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 47. Europe Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 48. Europe Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 50. Europe Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 51. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 52. Europe Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 53. Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Table 54. China Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 55. China Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 56. China Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 58. China Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 59. China Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 60. China Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 61. China Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Table 62. Japan Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 63. Japan Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 64. Japan Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 66. Japan Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 67. Japan Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 68. Japan Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 69. Japan Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Table 70. Regeneron Pharmaceuticals Company Information
Table 71. Regeneron Pharmaceuticals Description and Business Overview
Table 72. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product
Table 74. Regeneron Pharmaceuticals Recent Development
Table 75. Bayer HealthCare Company Information
Table 76. Bayer HealthCare Description and Business Overview
Table 77. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Bayer HealthCare Age Related Macular Degeneration Drug Product
Table 79. Bayer HealthCare Recent Development
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Age Related Macular Degeneration Drug Product
Table 84. Novartis Recent Development
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Roche Age Related Macular Degeneration Drug Product
Table 89. Roche Recent Development
Table 90. Kanghong Pharma Company Information
Table 91. Kanghong Pharma Description and Business Overview
Table 92. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Kanghong Pharma Age Related Macular Degeneration Drug Product
Table 94. Kanghong Pharma Recent Development
Table 95. Production Base and Market Concentration Rate of Raw Material
Table 96. Key Suppliers of Raw Materials
Table 97. Age Related Macular Degeneration Drug Distributors List
Table 98. Age Related Macular Degeneration Drug Customers List
Table 99. Age Related Macular Degeneration Drug Market Trends
Table 100. Age Related Macular Degeneration Drug Market Drivers
Table 101. Age Related Macular Degeneration Drug Market Challenges
Table 102. Age Related Macular Degeneration Drug Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration Drug Product Picture
Figure 2. Global Age Related Macular Degeneration Drug Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Age Related Macular Degeneration Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Lucentis Product Picture
Figure 5. Eylea Product Picture
Figure 6. Avastin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Age Related Macular Degeneration Drug Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Age Related Macular Degeneration Drug Sales Market Share by Application in 2024 & 2031
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Others Examples
Figure 13. Global Age Related Macular Degeneration Drug Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Age Related Macular Degeneration Drug Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 16. Global Age Related Macular Degeneration Drug Price Trends Growth Rate (2020-2031) & (USD/Unit)
Figure 17. Age Related Macular Degeneration Drug Report Years Considered
Figure 18. Global Market Age Related Macular Degeneration Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Age Related Macular Degeneration Drug Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Age Related Macular Degeneration Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 22. Europe Age Related Macular Degeneration Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 24. China Age Related Macular Degeneration Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. China Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 26. Japan Age Related Macular Degeneration Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2020-2031)
Figure 28. Global Age Related Macular Degeneration Drug Revenue Share by Type (2020-2025)
Figure 29. Global Age Related Macular Degeneration Drug Sales Share by Type (2026-2031)
Figure 30. Global Age Related Macular Degeneration Drug Revenue Share by Type (2026-2031)
Figure 31. Global Age Related Macular Degeneration Drug Revenue Share by Application (2020-2025)
Figure 32. Global Age Related Macular Degeneration Drug Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Age Related Macular Degeneration Drug Sales Share by Application (2026-2031)
Figure 34. Global Age Related Macular Degeneration Drug Revenue Share by Application (2026-2031)
Figure 35. Global Age Related Macular Degeneration Drug Sales Share by Company (2024)
Figure 36. Global Age Related Macular Degeneration Drug Revenue Share by Company (2024)
Figure 37. Global 5 Largest Age Related Macular Degeneration Drug Players Market Share by Revenue in Age Related Macular Degeneration Drug: 2020 & 2024
Figure 38. Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure 40. Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure 41. Age Related Macular Degeneration Drug Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232